| 5DYY: reference: Development of an in-vivo active reversible butyrylcholinesterase inhibitor., Kosak U, Brus B, Knez D, Sink R, Zakelj S, Trontelj J, Pislar A, Slenc J, Gobec M, Zivin M, Tratnjek L, Perse M, Salat K, Podkowa A, Filipek B, Nachon F, Brazzolotto X, Wieckowska A, Malawska B, Stojan J, Rascan IM, Kos J, Coquelle N, Colletier JP, Gobec S, Sci Rep. 2016 Dec 21;6:39495. doi: 10.1038/srep39495. PMID: 28000737 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).